Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Yuliya Bocharova"'
Autor:
Olga Kondratenko, Artem Lyamin, Tatiana Savinova, Yuliya Bocharova, Elena Vasilyeva, Igor Chebotar
Publikováno v:
Heliyon, Vol 9, Iss 6, Pp e16618- (2023)
Burkholderia cepacia complex (Bcc) bacteria are considered to be very dangerous players in cystic fibrosis (CF) pathogenesis and are a criterion for negative prognosis in CF cases. In this report, a pediatric case of paranasal sinusitis caused by Bur
Externí odkaz:
https://doaj.org/article/7505cb0ee2e14cbbb600ceb0d048545e
Publikováno v:
Diagnostic microbiology and infectious disease. 102(3)
The dissemination of multiple-drug resistant high virulent strains of Pseudomonas aeruginosa in patients with cystic fibrosis is of concern worldwide. Herein, we describe genomic characteristics of ST235 isolates recovered from cystic fibrosis patien
Autor:
Nikolay Mayanskiy, Dmitriy A. Shagin, Andrey A. Shelenkov, Yuliya Bocharova, I V Chebotar, Tatiana Savinova
Publikováno v:
Journal of Global Antimicrobial Resistance. 17:309-311
Objectives Alteration of the porin-encoding gene oprD by insertion sequences (ISs) is one mechanism conferring carbapenem resistance in Pseudomonas aeruginosa. Here we describe a carbapenem-resistant clinical P. aeruginosa isolate 36-989 harbouring a
Autor:
Nataliya Gordinskaya, I V Chebotar, Nikolay Mayanskiy, Yuliya Bocharova, Anna Lazareva, Svetlana Polikarpova, Tatiana Savinova
Publikováno v:
International journal of antimicrobial agents. 55(4)
Pseudomonas aeruginosa is a serious opportunistic pathogen demonstrating a high level of resistance to many groups of antibiotics, including carbapenems. This study aimed to characterise the molecular epidemiology and prevalence of mobile genetic ele
Autor:
Anna Lazareva, Yuliya Bocharova, Ol'ga Andreevna Kryzhanovskaya, Nikolay Mayanskiy, I V Chebotar
Publikováno v:
Annals of the Russian academy of medical sciences. 70:679-683
Background . Pseudomonas aeruginosa, the major nosocomial opportunistic pathogen, is an important cause of infectious morbidity and mortality among immunocompromised patients. Objective . To establish the role of metallo-β-lactamases (MBL) and efflu